📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Piramed

1.1 - Company Overview

Piramed Logo

Piramed

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of inhibitor-focused drug discovery and development of new medicines targeting cancer and immune inflammatory disorders, with applications across cardiovascular disease and pain.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Piramed

Bellwether Bio Logo

Bellwether Bio

HQ: United States Website
  • Description: Provider of novel cell-free DNA-based diagnostic technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bellwether Bio company profile →
Acrivon Therapeutics Logo

Acrivon Therapeutics

HQ: United States Website
  • Description: Provider of precision oncology therapeutics and companion diagnostics, leveraging the AP3 platform to develop drugs and OncoSignature tests that match therapies to tumor-driving mechanisms. Pipeline includes ACR-368, a phase 2 DNA damage response kinase inhibitor for solid cancers, and ACR-2316, a preclinical selective dual WEE1/PKMYT1 inhibitor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acrivon Therapeutics company profile →
Acepodia Logo

Acepodia

HQ: United States Website
  • Description: Provider of cancer cell therapies and platform technology, including ACC (Antibody-Cell Conjugation) to attach tumor-targeting antibodies to immune cells without genetic engineering; off-the-shelf allogeneic γδ2 T cell therapies; and ACC-γδ2 T cell candidates ACE1831 (CD20), ACE2016 (EGFR), and ACE1708 (PD-L1).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acepodia company profile →
Dendreon Logo

Dendreon

HQ: United States Website
  • Description: Provider of immunotherapy and cell therapy services, including PROVENGE (sipuleucel-T), an FDA-approved cellular immunotherapy for advanced prostate cancer; end-to-end cell therapy manufacturing; patient operations and logistics to deliver treatments within an 18-hour window across the U.S.; process and analytical development; and cGMP quality assurance and quality control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dendreon company profile →
ImmunoGen Logo

ImmunoGen

HQ: United States Website
  • Description: Provider of antibody-based anticancer therapeutics using TAP, ELAHERE for platinum-resistant ovarian cancer; investigational IMGN632 for acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm; mirvetuximab soravtansine (monotherapy, with bevacizumab or carboplatin) for platinum-sensitive ovarian cancers; and IMGN151 for recurrent endometrial and high-grade serous epithelial ovarian, primary peritoneal, or fallopian tube cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ImmunoGen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Piramed

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Piramed

2.2 - Growth funds investing in similar companies to Piramed

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Piramed

4.2 - Public trading comparable groups for Piramed

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Piramed

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Piramed

What does Piramed do?

Piramed is a provider of inhibitor-focused drug discovery and development of new medicines targeting cancer and immune inflammatory disorders, with applications across cardiovascular disease and pain.

Who are Piramed's competitors?

Piramed's competitors and similar companies include Bellwether Bio, Acrivon Therapeutics, Acepodia, Dendreon, and ImmunoGen.

Where is Piramed headquartered?

Piramed is headquartered in United Kingdom.

How many employees does Piramed have?

Piramed has 1,000 employees 🔒.

When was Piramed founded?

Piramed was founded in 2010 🔒.

What sector and industry vertical is Piramed in?

Piramed is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Piramed

Who are the top strategic acquirers in Piramed's sector and industry

Top strategic M&A buyers and acquirers in Piramed's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Piramed?

Top strategic M&A buyers groups and sectors for Piramed include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Piramed's sector and industry vertical

Which are the top PE firms investing in Piramed's sector and industry vertical?

Top PE firms investing in Piramed's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Piramed's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Piramed's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Piramed's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Piramed include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Piramed's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Piramed?

The key public trading comparables and valuation benchmarks for Piramed include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Piramed for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Piramed with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Piramed's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Piramed with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Piramed's' sector and industry vertical?

Access recent funding rounds and capital raises in Piramed's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Piramed